Advisory Committee

Jessie Modlin, PharmD, BCOP, is a clinical oncology pharmacist in the Oncology Specialty Pharmacy at St. Luke’s Cancer Institute in Boise, Idaho. Dr. Modlin has worked in various areas of oncology, including outpatient infusion and clinical research. She also serves as affiliate faculty with Idaho State University and provides consultation services for ACT Genetics. Dr. Modin is a board member of the Idaho Society of Clinical Oncology. Her interests include symptom management, pharmacogenomics, and financial toxicity. Dr. Modin received her Doctor of Pharmacy degree from the University of Wyoming in Laramie, Wyoming. She completed her general pharmacy residency at Franciscan Health in Tacoma, Washington, and completed her oncology residency at St. Luke’s Cancer Institute in Boise, Idaho.